Janux Therapeutics JANX Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Janux Therapeutics's investment purchases?
- Janux Therapeutics (JANX) reported investment purchases of $112.75M in Q1 2026.
- How has Janux Therapeutics's investment purchases changed year-over-year?
- Janux Therapeutics's investment purchases decreased by 69.6% year-over-year, from $371.29M to $112.75M.
- What is the long-term trend for Janux Therapeutics's investment purchases?
- Over 4 years (2021 to 2025), Janux Therapeutics's investment purchases has grown at a 10.5% compound annual growth rate (CAGR), from $473.63M to $705.22M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.